Patient Support Line 1-866-433-8000, Monday - Friday: 8:00 AM to 8:00 PM ET
Download Helpful Materials About Metastatic Breast Cancer
The resources below were created to help you throughout every step of treatment with KISQALI. You can use them to help guide discussions with your care team or to locate helpful organizations. Save these materials to your mobile device or tablet, or print them, so you can access this information at home or on the go.
Patient brochure
Find answers to questions you may have about KISQALI + hormone therapy for HR+, HER2- metastatic breast cancer (mBC).
Folleto para pacientes
Encuentre respuestas a muchas de sus preguntas sobre KISQALI + terapia hormona y el cáncer de mama metastásico (mBC) HR+, HER2–.
Appointment guide
This guide includes tips and conversation starters to help you feel empowered when discussing important treatment-related information with your doctor.
Day-to-day patient resources
Learn about independent support organizations that can offer services to complement metastatic breast cancer treatment plans and care, such as transportation, lodging, healthy meals, home cleaning, and more.
Recursos del día a día para pacientes
Conozca las organizaciones de apoyo independientes que ofrecen servicios para complementar los planes de tratamiento y la atención del cáncer de mama metastásico, como servicios de transporte, alojamiento, comidas saludables, limpieza del hogar y más.
Metastatic breast cancer guide
This comprehensive guide includes information, tips, and support resources to help you navigate an mBC diagnosis.
Guía sobre el cáncer de mama metastásico
Esta guía exhaustiva incluye información, consejos y recursos de apoyo que le ayudarán a transitar un diagnóstico de cáncer de mama metastásico.
KISQALI is not approved for use with tamoxifen.
KISQALI no está aprobado para la administración con tamoxifeno.
HER2-, human epidermal growth factor receptor 2-negative; HR+, hormone receptor-positive.
HER2-, factor de crecimiento epidérmico humano 2 negativo; HR+, receptor hormonal positivo.
KISQALI no está aprobado para la administración con tamoxifeno.
HER2-, human epidermal growth factor receptor 2-negative; HR+, hormone receptor-positive.
HER2-, factor de crecimiento epidérmico humano 2 negativo; HR+, receptor hormonal positivo.
